Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)

NCT00567723 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT00567723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-IV, Long-term, Observational Safety Study in End Stage Renal Disease Subjects Treated With Lanthanum Carbonate (Fosrenol)
Lead sponsor
Shire
Phase
Observational
Overall status
Completed
Start date
April 25, 2006
Completion date
June 7, 2016
Enrollment
2,105 (actual)
Sites
199

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia